IRIS
Denti, Michela Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.482
AS - Asia 3.251
EU - Europa 2.666
SA - Sud America 476
AF - Africa 62
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.950
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.358
SG - Singapore 1.418
CN - Cina 664
VN - Vietnam 617
RU - Federazione Russa 436
BR - Brasile 402
IT - Italia 361
UA - Ucraina 324
FI - Finlandia 305
SE - Svezia 297
GB - Regno Unito 220
DE - Germania 183
FR - Francia 156
LV - Lettonia 128
KR - Corea 127
IN - India 86
CA - Canada 77
NL - Olanda 62
BG - Bulgaria 50
HK - Hong Kong 38
ES - Italia 37
ID - Indonesia 33
IQ - Iraq 32
TR - Turchia 31
JO - Giordania 30
BD - Bangladesh 28
ZA - Sudafrica 26
PL - Polonia 24
AR - Argentina 23
MX - Messico 23
JP - Giappone 22
IR - Iran 19
AT - Austria 17
VE - Venezuela 17
PK - Pakistan 16
MY - Malesia 15
LT - Lituania 11
IE - Irlanda 10
AU - Australia 9
EC - Ecuador 8
NP - Nepal 8
UZ - Uzbekistan 8
BE - Belgio 7
CH - Svizzera 7
CL - Cile 7
CO - Colombia 7
EG - Egitto 7
JM - Giamaica 6
KE - Kenya 6
MA - Marocco 6
SA - Arabia Saudita 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
GR - Grecia 4
HR - Croazia 4
KZ - Kazakistan 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
NI - Nicaragua 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TW - Taiwan 3
AL - Albania 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
MD - Moldavia 1
Totale 14.942
Salva come PNG Salva come JPEG
Città #
Singapore 882
Chandler 832
Ashburn 817
Jacksonville 676
Fairfield 648
San Jose 419
Dallas 344
Woodbridge 322
Wilmington 275
Seattle 267
Houston 262
Santa Clara 253
Ann Arbor 240
Columbus 237
San Mateo 234
Cambridge 213
Princeton 207
Moscow 195
Beijing 180
Helsinki 175
Ho Chi Minh City 166
Hanoi 139
The Dalles 138
New York 133
Riga 128
Seoul 123
Lauterbourg 110
Los Angeles 109
Dearborn 80
Trento 79
Boardman 71
Hefei 61
Buffalo 60
Council Bluffs 60
São Paulo 51
Munich 49
San Diego 48
Sofia 46
Orem 44
North Bergen 41
London 38
Bremen 36
Fremont 34
Da Nang 31
Dong Ket 31
Hong Kong 30
Delft 28
Lawrence 28
Chicago 27
Jakarta 26
Ottawa 26
Rome 26
Haiphong 24
Chennai 23
Denver 23
Frankfurt am Main 23
Milan 23
Phoenix 23
Warsaw 22
Como 21
Lappeenranta 20
Johannesburg 19
Norwalk 19
Toronto 19
Stockholm 18
Tokyo 18
Brooklyn 17
Poplar 17
Redondo Beach 17
San Paolo di Civitate 17
Guangzhou 15
Manchester 15
Nuremberg 15
Tehran 15
Belo Horizonte 14
Biên Hòa 14
Izmir 14
Atlanta 13
Montreal 13
Amsterdam 12
Des Moines 12
Mumbai 12
Boston 11
Kilburn 11
New Delhi 11
Shanghai 11
Badajoz 10
Hillsboro 10
Hải Dương 10
Ipoh 10
Rio de Janeiro 10
Salt Lake City 10
Verona 10
Vienna 10
Washington 10
Ankara 9
Falkenstein 9
Kunming 9
Turku 9
Tân Tiến 9
Totale 10.481
Salva come PNG Salva come JPEG
Nome #
The short-term impact of probiotic consumption on the oral cavity microbiome 270
The miR-15/107 Family of microRNA Genes Regulates CDK5R1/p35 with Implications for Alzheimer’s Disease Pathogenesis 223
Enhanced microbial diversity in the saliva microbiome induced by short-term probiotic intake revealed by 16S rRNA sequencing on the IonTorrent PGM platform 215
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 213
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 204
Statistical analysis of a Bayesian classifier based on the expression of miRNAs 198
Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations 198
A new splicing isoform of Cacna2d4 mimicking the effects of c.2451insC mutation in the retina: Novel molecular and electrophysiological insights 194
RNA intereference mediated therapy for neurodegenerative diseases 191
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 190
Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue. A focus on atrial fibrillation 189
Reduced miR-659-3p levels correlate with progranulin increase in hypoxic conditions: Implications for frontotemporal dementia 188
An electroporation protocol for efficient DNA transfection in PC12 cells 182
microRNAs make the call in cancer personalized medicine 176
Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects 175
microRNA-375 expression distinguishes neuroendocrine from non-neuroendocrine lung tumours in FFPE samples 170
A network in FrontoTemporal Dementia - an RNA perspective 168
A novel RNA-binding protein from Triturus carnifex identified by RNA-ligand screening with the newt hammerhead ribozyme 167
Delivery is key: Lessons learnt from developing splice-switching antisense therapies 167
Oligonucleotide therapy 166
New Platform for the Direct Profiling of microRNAs in Biofluids 165
Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases 164
AAV-Mediated Allele-Specific RNA Interference of a Common Dominant Rhodopsin Mutation Causing Retinitis Pigmentosa 163
Comparison of different methods to extract RNA from cardiac tissue for miRNA profiling by qRT-PCR 163
Splicing-correcting therapeutic approaches for retinal dystrophies: where endogenous gene regulation and specificity matter. 160
MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression 158
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 157
Antisense RNA-mediated exon skipping in gene therapy 156
miR-205 expression levels in non-small cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. 156
DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer 154
MicroRNAs in epithelial ovarian cancer 153
AAV-mediated Allele-specific RNA interference of a common dominant Rhodopsin mutation causing Retinitis Pigmentosa 153
A new vector, based on the polII promoter of U1 snRNA gene, for the expression of siRNAs in mammalian cells 152
A chimeric adeno-associated virus/antisense-U1small nuclear RNA effectively rescues dystrophin synthesis and muscle function by local treatment of mdx mice 151
miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples 150
Identification of new p53 target microRNAs by bioinformatics and functional analysis 148
Circulating miR-127-3p as a potential biomarker for differential diagnosis in frontotemporal dementia 147
A loxP-containing pol II promoter for RNA interference is reversibly regulated by Cre recombinase 146
Heterogeneity of Large Cell Carcinoma of the Lung: An Immunophenotypic and miRNA-Based Analysis. 144
Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation 143
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 142
Functional analysis of miRNAs involved in the regulation of the transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8 in epithelial ovarian cancer 140
Delivery of oligonucleotide-based therapeutics: challenges and opportunities 140
Antisense RNA-induced exon-skipping for the gene therapy of frontotemporal dementia and parkinsonism associated with chromosome 17 (ftdp-17) 138
MicroRNAs as lung cancer biomarkers 137
Long term benefit of AAV/antisense-mediated exon skipping in dystrophic mice 135
Long-term benefit of adeno-associated virus/antisense-mediated exon skipping in dystrophic mice 135
Circulating microRNAs in Neurodegenerative Diseases 134
71 nucleotides from the terminal right part of PSTVd is the sufficient minimum of RNA capable of sustaining specific binding to tomato protein Virp1 132
Antisense RNA -induced exon-skipping for the gene therapy of Frontotemporal Dementia and Parkinsonism 130
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 128
A study on the newt hammerhead ribozyme : association to RNA-binding proteins and intracellular localisation 128
MicroRNA and Lung Cancer 128
A vector for siRNA expression in mammalian cells that relies on polII-dependent transcription and produces asymmetric accumulation of one siRNA strand 125
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders 125
Measurements methods for the development of microRNA-based tests for cancer diagnosis 124
Analisi della struttura e dell¿attivit¿ autocatalitica di trascritti dimerici ¿BglII¿ in Triturus 121
MIR-NATs repress MAPT translation and aid proteostasis in neurodegeneration 119
Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect 118
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model 117
Fabry Disease: Antisense Therapeutics for intronic variations causing mis-spliced messenger RNA and active-site-specific chaperones (ASSC) for conformational enzyme defects 117
Antisense RNA-mediated exon-skipping for gene therapy 116
mRNA fate: Life and death of the mRNA in the cytoplasm 114
Small RNA molecules of great utility as diagnostic biomarkers in lung cancer 113
Short interfering RNAs specific for potato spindle tuber viroid are found in the cytoplasm but not in the nucleus 111
New circuits between miRNAs and transcription factors Hoxa9, Hoxa10, Hoxa11 and Pax8: possible identification of therapeutic targets for epithelial ovarian cancer treatment 111
Circulating cell-free microRNAs as biomarkers for neurodegenerative diseases 111
HCS-Splice: A High-Content Screening Method to Advance the Discovery of RNA Splicing-Modulating Therapeutics 108
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 108
Il ribozima di tritone: struttura ed applicazioni 108
Integrative microRNAome analysis of skeletal muscle of Colossoma macropomum (tambaqui), Piaractus mesopotamicus (pacu), and the hybrid tambacu, based on next-generation sequencing data 108
PMP70 knock-down generates oxidative stress and pro-inflammatory cytokine production in C6 glial cells 107
Replicating potato spindle tuber viroid RNA is accompanied by short RNA fragments that are characteristic of post-transcriptional gene silencing 107
Uso di un ribozima di vertebrati per l'inattivazione del gene MGMT in cellule CHO 99
RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: a model system to study PMP70 function 99
AAV-mediated retinal gene transfer in animal models of retinal degeneration 98
Characterization of the RNA motif responsible for the specific interaction of potato spindle tuber viroid RNA (PSTVd) and the tomato protein Virp1 97
The newt hammerhead ribozyme: structure and applications 96
Virp1 is a host protein with a major role in potato spindle tuber viroid infection in Nicotiana plants 96
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia 94
miR-92a-3p and miR-320a are Upregulated in Plasma Neuron-Derived Extracellular Vesicles of Patients with Frontotemporal Dementia 94
Preferential silencing of a common dominant rhodopsin mutation does not inhibit retinal degeneration in a transgenic model 94
Uso di nuove proprietà dell' RNA per la terapia genica di infezioni da HIV = Use of new RNA properties for gene therapy of HIV infections 92
MicroRNAs in epithelial ovarian cancer 92
Study on the affinity and specificity of the interaction between Potato Spindle Tuber viroid and tomato protein Virp1 91
La ribonucleoparticella del ribozima di tritone: fossile molecolare o una nuova particella coinvolta nel ¿processing¿ dell¿RNA? 89
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study 88
Towards functional analysis of BVRB, a gene encoding for a viroid binding protein 88
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 87
SA-ODG platform: a semi-automated and PCR-free method to analyse microRNAs in solid tissues 85
Identification of the RNA binding domain of Virp-1 85
U1snRNA-mediated exon skipping for the therapy of Duchenne Muscular Dystrophy: towards a clinical trial 84
The motif in the Terminal Right Part of Potato Spindle Tuber Viroid is the determinant of specific in vitro recognition by tomato RNA-binding protein Virp1 83
Characterisation of the protein components of the newt hammerhead ribozyme RNP 83
Replicating viroid RNA is accompanied by short RNA fragments that are characteristic of posttranscriptional gene silencing 83
Use of new RNA properties for gene therapy of HIV infections 82
Virp1, a host factor necessary for replication of nuclear viroids 81
Identification of miRNAs Bound to an RNA of Interest by MicroRNA Capture Affinity Technology (miR-CATCH) 81
Exon-skipping mediated by the systemic delivery of AAV constructs expressing antisense-snRNAs restores dystrophin and muscular functionality in body-wide skeletal muscles of mdx mice 80
Body-wide rescue of dystrophin and muscle function in mdx mice by antisense-snRNAs mediated exon-skipping 79
Totale 13.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 1.146
selected - selezionate 0
volume - volumi 3.378
Totale 64.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021364 0 0 0 0 0 0 0 0 0 72 192 100
2021/20221.284 57 238 5 72 89 25 46 202 75 125 103 247
2022/20231.714 239 198 26 266 191 257 7 117 238 12 76 87
2023/2024658 48 53 38 24 67 153 44 56 6 59 32 78
2024/20252.603 15 29 128 508 121 341 44 178 286 491 203 259
2025/20264.852 437 110 647 779 555 459 919 146 422 378 0 0
Totale 15.197